1. Home
  2. ENSC vs JDZG Comparison

ENSC vs JDZG Comparison

Compare ENSC & JDZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • JDZG
  • Stock Information
  • Founded
  • ENSC 2003
  • JDZG 2020
  • Country
  • ENSC United States
  • JDZG China
  • Employees
  • ENSC N/A
  • JDZG N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • JDZG Other Consumer Services
  • Sector
  • ENSC Health Care
  • JDZG Real Estate
  • Exchange
  • ENSC Nasdaq
  • JDZG Nasdaq
  • Market Cap
  • ENSC 5.2M
  • JDZG 5.7M
  • IPO Year
  • ENSC N/A
  • JDZG 2024
  • Fundamental
  • Price
  • ENSC $2.14
  • JDZG $1.76
  • Analyst Decision
  • ENSC
  • JDZG
  • Analyst Count
  • ENSC 0
  • JDZG 0
  • Target Price
  • ENSC N/A
  • JDZG N/A
  • AVG Volume (30 Days)
  • ENSC 84.6K
  • JDZG 129.9K
  • Earning Date
  • ENSC 08-13-2025
  • JDZG 04-25-2025
  • Dividend Yield
  • ENSC N/A
  • JDZG N/A
  • EPS Growth
  • ENSC N/A
  • JDZG N/A
  • EPS
  • ENSC N/A
  • JDZG 0.25
  • Revenue
  • ENSC $7,413,722.00
  • JDZG $2,567,741.00
  • Revenue This Year
  • ENSC N/A
  • JDZG N/A
  • Revenue Next Year
  • ENSC $1,354.55
  • JDZG N/A
  • P/E Ratio
  • ENSC N/A
  • JDZG $7.03
  • Revenue Growth
  • ENSC 415.58
  • JDZG 20.36
  • 52 Week Low
  • ENSC $1.62
  • JDZG $1.58
  • 52 Week High
  • ENSC $14.67
  • JDZG $21.28
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 51.93
  • JDZG 40.50
  • Support Level
  • ENSC $2.03
  • JDZG $1.71
  • Resistance Level
  • ENSC $2.21
  • JDZG $2.13
  • Average True Range (ATR)
  • ENSC 0.09
  • JDZG 0.15
  • MACD
  • ENSC 0.01
  • JDZG 0.03
  • Stochastic Oscillator
  • ENSC 63.38
  • JDZG 13.95

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About JDZG JIADE LIMITED Common stock

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

Share on Social Networks: